Literature DB >> 1394806

Inhibition of growth factor binding and intracellular Ca2+ signalling by dextran sulfates of different sizes and degrees of sulfation.

G Powis1, M Seewald, M Hoke.   

Abstract

The ability of dextran sulfates of varying molecular sizes (5-500 kDa) and degrees of sulfate substitution (0.3-1.9) to inhibit the binding of platelet-derived growth factor (PDGF) to intact Swiss 3T3 fibroblasts and to inhibit inositol(1,4,5)trisphosphate-dependent release of Ca2+ in permeabilized Swiss 3T3 cells was examined in the present study. Significant correlations were found between increased molecular size of the dextran sulfates and inhibition of both PDGF binding (r = 0.77) and Ca2+ release (r = 0.72). The degree of sulfate substitution did not correlate with inhibition of either activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394806     DOI: 10.1007/bf00685602

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  26 in total

1.  Quinoneimines as substrates for quinone reductase (NAD(P)H: (quinone-acceptor)oxidoreductase) and the effect of dicumarol on their cytotoxicity.

Authors:  G Powis; K L See; K S Santone; D C Melder; E M Hodnett
Journal:  Biochem Pharmacol       Date:  1987-08-01       Impact factor: 5.858

2.  Effect of collagen and acid polysaccharides on the growth of BHK-21 cells in semi-solid media.

Authors:  F K Sanders; J D Smith
Journal:  Nature       Date:  1970-08-01       Impact factor: 49.962

Review 3.  Receptor-mediated endocytosis: concepts emerging from the LDL receptor system.

Authors:  J L Goldstein; M S Brown; R G Anderson; D W Russell; W J Schneider
Journal:  Annu Rev Cell Biol       Date:  1985

4.  Dextran sulfate and pentosan polysulfate (HOE/BAY 946), potent anti-HIV-agents, inhibit protein kinase C.

Authors:  W Schiebler; C Schmidt; P Weber
Journal:  J Protein Chem       Date:  1989-06

5.  Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A.

Authors:  C E Hensey; D Boscoboinik; A Azzi
Journal:  FEBS Lett       Date:  1989-11-20       Impact factor: 4.124

6.  Dextran sulfate inhibits the inositol 1,4,5-trisphosphate-induced Ca2+ release from skinned and cultured smooth muscle cells.

Authors:  H Yamamoto; H Kanaide; M Nakamura
Journal:  Eur J Pharmacol       Date:  1991-03-25       Impact factor: 4.432

7.  Inhibition of growth factor binding, Ca2+ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin.

Authors:  G Powis; M J Seewald; D Melder; M Hoke; C Gratas; T A Christensen; D E Chapman
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.

Authors:  R J Coffey; E B Leof; G D Shipley; H L Moses
Journal:  J Cell Physiol       Date:  1987-07       Impact factor: 6.384

9.  High molecular weight dextran sulfate inhibits intracellular Ca2+ release and decreases growth factor-induced increases in intracellular free Ca2+ in Swiss 3T3 fibroblasts.

Authors:  M J Seewald; J J Schlager; R A Olsen; D C Melder; G Powis
Journal:  Cancer Commun       Date:  1989

10.  Suramin binds to platelet-derived growth factor and inhibits its biological activity.

Authors:  M Hosang
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

View more
  1 in total

1.  Carboxymethyl benzylamide dextrans inhibit breast cell growth.

Authors:  R Bagheri-Yarmand; P Bittoun; J Champion; D Letourneur; J Jozefonvicz; S Fermandjian; M Crépin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-12       Impact factor: 2.416

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.